<DOC>
	<DOCNO>NCT01023204</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety paclitaxel give weekly patient advance recurrent breast cancer</brief_summary>
	<brief_title>Phase II Study Weekly Paclitaxel ( BMS-181339 ) Patient With Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patients primary advance inoperable disease refractory chemotherapy Patients recurrent disease follow postoperative adjuvant chemotherapy Patients amenable postrecurrence chemotherapy Patients serious , uncontrolled medical illness Patients previous therapy taxanes</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>